InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Erbez Georgia, Chief Financial Officer. Officer active across 2 companies, notably Harpoon Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €143k. Activity tracked since 22 September 2021. The latest transaction was disclosed on 5 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
26,875 shares0Common StockSEC:0000905148-25-000440:0
50,000 shares0Common StockSEC:0000905148-24-002705:0
10,300 shares@ US$8.1050.0% of flowCommon StockSEC:0001209191-21-057342:0
Ideal exit: 19 Jun 2022 (T+270)
10,300 shares@ US$8.1050.0% of flowCommon StockSEC:0001209191-21-057342
Ideal exit: 19 Jun 2022 (T+270)
4 of 4 declarations
About Erbez Georgia
Georgia Erbez is the Chief Financial Officer of Harpoon Therapeutics, Inc. She oversees the company's financial activities, including financial planning and risk management. Her expertise in finance is essential in supporting Harpoon's strategic objectives.
